☆ 4.7 Review

Metabolism of pancreatic neuroendocrine tumors: what can omics tell us?

FRONTIERS IN ENDOCRINOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Hindering NAT8L expression in hepatocellular carcinoma increases cytosolic aspartate delivery that fosters pentose phosphate pathway and purine biosynthesis promoting cell proliferation

Pamela De Falco et al.

Summary: N-acetylaspartate (NAA) is synthesized by the mitochondrial enzyme NAT8L using acetyl-CoA and aspartate as substrates. The modulation of NAT8L expression has been found to affect the metabolic adaptations and proliferative capability of hepatocellular carcinoma cells. NAT8L downregulation increases cell proliferation, while over-expression decreases cell growth. Mechanistically, NAT8L downregulation promotes aspartate outflow from mitochondria to enhance glucose flux into the pentose phosphate pathway, resulting in increased purine biosynthesis. These findings suggest that NAT8L plays a critical role in regulating cell proliferation through metabolic rewiring.

REDOX BIOLOGY (2023)

Add to Collection

Article Endocrinology & Metabolism

Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression

Johannes F. Fahrmann et al.

Summary: This study identified novel circulating protein markers associated with disease progression in MEN1-related dpNET through mass spectrometry-based proteomic profiling.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Add to Collection

Article Oncology

Orlistat Induces Ferroptosis in Pancreatic Neuroendocrine Tumors by Inactivating the MAPK Pathway

Mujie Ye et al.

Summary: Orlistat inhibits the progression of pancreatic neuroendocrine tumors (pNETs) by inducing ferroptosis mediated by inactivation of the MAPK signaling pathway. It is a promising candidate for the treatment of pNETs.

JOURNAL OF CANCER (2023)

Add to Collection

Review Oncology

Acetyl-CoA metabolism in cancer

David A. Guertin et al.

Summary: This review provides an overview of acetyl-CoA metabolism in health and cancer, and discusses emerging therapeutic strategies for targeting these metabolic pathways. Acetyl-CoA plays a central role in cell metabolism, serving as a building block for fatty acid and isoprenoid biosynthesis, as well as a signalling metabolite through lysine acetylation. Advances in understanding acetyl-CoA metabolism and the development of therapeutic agents targeting acetyl-CoA synthesis show promise in cancer treatment.

NATURE REVIEWS CANCER (2023)

Add to Collection

Review Oncology

Expanding Therapeutic Opportunities for Extrapulmonary Neuroendocrine Carcinoma

Melissa Frizziero et al.

Summary: Poorly differentiated neuroendocrine carcinomas (PD-NEC) are rare cancers that have gained attention due to improved diagnostic methods and the phenomenon of NE lineage plasticity. However, effective treatment options for PD-NEC patients are challenging due to the lack of targetable molecular drivers, limited preclinical models, and validated biomarkers.

CLINICAL CANCER RESEARCH (2022)

Add to Collection

Article Oncology

Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms

James R. Larkin et al.

Summary: This study demonstrates that biomarkers within the blood metabolome analyzed by NMR metabolomics can aid in the early diagnosis of cancer and distinguish between patients with and without metastatic disease in a mixed population of patients referred from primary care.

CLINICAL CANCER RESEARCH (2022)

Add to Collection

Review Biotechnology & Applied Microbiology

Lipogenesis inhibitors: therapeutic opportunities and challenges

Battsetseg Batchuluun et al.

Summary: Fatty acids play essential roles in cellular survival and function as bioenergetic substrates, structural components, and signaling molecules. Cells have evolved de novo lipogenesis (DNL) to generate fatty acids from alternative carbon sources. However, abnormal upregulation of DNL is associated with various pathologies. Inhibiting core enzymes of DNL represents a potential therapeutic strategy, and several synthetic DNL inhibitors are currently in development. Aberrant upregulation of DNL is implicated in conditions such as cardiovascular disease, metabolic disorders, and cancers.

NATURE REVIEWS DRUG DISCOVERY (2022)

Add to Collection

Review Biotechnology & Applied Microbiology

Targeting cancer metabolism in the era of precision oncology

Zachary E. Stine et al.

Summary: In the past century, there have been significant advancements in targeting cancer metabolism, but progress in the past decade has been limited. Some metabolism-based drugs for cancer have been successfully developed and are in clinical trials. However, consideration of the metabolism of non-cancer cells is crucial for successful treatment of cancer.

NATURE REVIEWS DRUG DISCOVERY (2022)

Add to Collection

Review Oncology

Hallmarks of Cancer: New Dimensions

Douglas Hanahan

Summary: The concept of the hallmarks of cancer is a tool for simplifying the complexity of cancer phenotypes and genotypes into basic principles. This article proposes phenotypic plasticity and disrupted differentiation as distinct hallmark capabilities, and discusses nonmutational epigenetic reprogramming and polymorphic microbiomes as enabling characteristics. Additionally, the importance of senescent cells in the tumor microenvironment is highlighted. The integrative concept of the hallmarks of cancer helps in understanding the mechanisms of cancer development and applying that knowledge to cancer medicine.

CANCER DISCOVERY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Tryptophan metabolism and disposition in cancer biology and immunotherapy

Abdulla A-B Badawy

Summary: Tumors utilize tryptophan and its metabolites to promote growth and evade host defenses. By up-regulating tryptophan transporters and key enzymes involved in tryptophan degradation, tumors are able to recruit tryptophan. This results in the accumulation of aryl hydrocarbon receptor ligands and the depletion of NAD(+) in the host. Tumors also up-regulate tryptophan transporters to further increase tryptophan supply. Therefore, inhibiting tumor demand for tryptophan and tryptophan transport may be a potential strategy to combat tumor immune escape.

BIOSCIENCE REPORTS (2022)

Add to Collection

Article Health Care Sciences & Services

Incidence and survival of neuroendocrine neoplasia in England 1995-2018: A retrospective, population- based study

Benjamin E. White et al.

Summary: The incidence of neuroendocrine neoplasias (NEN) is increasing in England, but survival rates are also improving over time. The relatively high survival rate compared to other cancers poses challenges for long-term outcomes and funding for care.

LANCET REGIONAL HEALTH-EUROPE (2022)

Add to Collection

Article Cell Biology

Glutathione S-transferase A2 promotes hepatocellular carcinoma recurrence after liver transplantation through modulating reactive oxygen species metabolism

Kevin Tak-Pan Ng et al.

Summary: This study suggests that GSTA2 plays a crucial role in the early phase after liver transplantation, significantly associated with HCC recurrence and survival. The polymorphism of GSTA2 is related to the survival rate of HCC patients, and enhancing GSTA2 levels can protect HCC cells from H2O2-induced cell death.

CELL DEATH DISCOVERY (2021)

Add to Collection

Article Oncology

Tryptophan metabolism induced by TDO2 promotes prostatic cancer chemotherapy resistance in a AhR/c-Myc dependent manner

Fan Li et al.

Summary: Higher expression of TDO2 was found in tumor tissues, with increased Trp metabolism. Overexpression of TDO2 in prostate cancer cell lines promoted Trp metabolism and resulted in drug resistance development. Mechanistically, Trp metabolite Kyn was shown to activate AhR and c-Myc.

BMC CANCER (2021)

Add to Collection

Review Oncology

Serine, glycine and one-carbon metabolism in cancer (Review)

Sijing Pan et al.

Summary: Serine/glycine biosynthesis and one-carbon metabolism play crucial roles in sustaining cancer cell survival and proliferation by providing essential macromolecules and maintaining redox balance in the tumor microenvironment. Understanding the regulatory mechanisms of key enzymes and intermediates in these pathways may lead to new opportunities for cancer drug development, dietary interventions, and biomarker identification.

INTERNATIONAL JOURNAL OF ONCOLOGY (2021)

Add to Collection

Review Immunology

Cancer Focus Lipid metabolism and cancer

Xueli Bian et al.

Summary: Dysregulation of lipid metabolism plays a significant role in cancer progression, and understanding the regulation and disruption of lipid metabolism in cancer cells have led to promising clinical approaches in cancer therapy.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Add to Collection

Article Cell Biology

Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms

Kevin C. Yang et al.

Summary: Pancreatic neuroendocrine neoplasms (PNENs) are biologically and clinically heterogeneous. Through multi-omics analysis, four subgroups have been identified with distinct survival probabilities and metabolic features. The Stromal/Mesenchymal subgroup shows molecular characteristics of YAP1/WWTR1(TAZ) activation suggesting involvement of the Hippo signaling pathway in PNENs.

CELL REPORTS (2021)

Add to Collection

Article Oncology

Metabolomics in cancer research and emerging applications in clinical oncology

Daniel R. Schmidt et al.

Summary: Cancer has complex effects on cellular and systemic metabolism, with metabolomics playing a crucial role in providing insights for cancer diagnosis, monitoring, and therapy. Advances in technology have expanded the applications of metabolomics in clinical research, with the potential to further enhance cancer patient management in the future.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Cell Biology

Creatine promotes cancer metastasis through activation of Smad2/3

Liwen Zhang et al.

Summary: The study found that creatine promotes colorectal and breast cancer metastasis and shortens mouse survival. By inhibiting GATM or MPS1, cancer metastasis can be reduced and mouse survival can be extended.

CELL METABOLISM (2021)

Add to Collection

Article Endocrinology & Metabolism

Mass spectrometry imaging identifies metabolic patterns associated with malignant potential in pheochromocytoma and paraganglioma

Masanori Murakami et al.

Summary: This study comprehensively characterized the metabolic profiles of PPGLs using MALDI-MSI, revealing distinct tissue metabolomic profiles related to tumor genotypes. Additionally, significantly altered metabolites in the kynurenine pathway in metastatic PPGLs were identified, which may aid in predicting malignant potential. Further validation studies are needed to confirm these findings.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Value of glycogen synthase 2 in intrahepatic cholangiocarcinoma prognosis assessment and its influence on the activity of cancer cells

A. Sigen et al.

Summary: Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver tumor with increasing incidence worldwide. The study revealed that low GYS2 expression in ICC predicted unfavorable patient outcomes, while GYS2 overexpression significantly impaired the proliferation, migration, and invasion of cholangiocarcinoma cells via activating the P53 pathway. GYS2 could become a potential therapeutic target for ICC patients.

BIOENGINEERED (2021)

Add to Collection

Review Biochemistry & Molecular Biology

The functional roles of TCA cycle metabolites in cancer

Joseph Eniafe et al.

Summary: The tricarboxylic acid cycle plays a vital role in cancer initiation and progression by modulating cellular activities through its intermediates. Understanding the roles and molecular mechanisms of TCA metabolites in oncogenesis could lead to the development of novel metabolite-based cancer therapy in the future.

ONCOGENE (2021)

Add to Collection

Article Oncology

Prognostic transcriptome classes of duodenopancreatic neuroendocrine tumors

Marc Diedisheim et al.

Summary: The study aimed to provide insights into potential prognostic information for Duodenopancreatic neuroendocrine tumors (DPNETs) through transcriptome classification, identifying three distinct molecular groups associated with different outcomes. The expression of the FGA gene was found to be associated with disease-free survival and validated on independent cohorts, offering new perspectives for prognostic classification.

ENDOCRINE-RELATED CANCER (2021)

Add to Collection

Article Endocrinology & Metabolism

A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression

Johannes F. Fahrmann et al.

Summary: This study suggests that circulating polyamines may play a role in the progression of dpNETs in patients with MEN1, highlighting their potential as biomarkers for monitoring disease aggressiveness.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Add to Collection

Article Oncology

Comprehensive Plasma Metabolomic Profile of Patients with Advanced Neuroendocrine Tumors (NETs). Diagnostic and Biological Relevance

Beatriz Soldevilla et al.

Summary: Metabolic flexibility is a key feature of cancer, and this study provides a comprehensive analysis of the metabolic profile of NET patients, identifying a unique metabolic signature in plasma with potential clinical applications. The study also identifies a reduced set of metabolites with high diagnostic accuracy and reveals 32 enriched metabolic pathways related to TCA cycle and amino acid metabolism in NETs.

CANCERS (2021)

Add to Collection

Article Medicine, General & Internal

Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States

Zihan Xu et al.

Summary: The study analyzed epidemiologic and survival data of 43,751 patients with GEP-NETs from 1975 to 2015, finding a continuous increase in the incidence and prevalence of GEP-NETs, especially among patients with rectal GEP-NETs. Additionally, a nomogram with 5 prognostic parameters was established to accurately quantify the risk of death among patients with GEP-NETs, showing satisfactory clinical practicality.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Single-cell RNA sequencing reveals spatiotemporal heterogeneity and malignant progression in pancreatic neuroendocrine tumor

Yu Zhou et al.

Summary: Utilizing single-cell RNA sequencing technology, this study uncovered both intra- and inter-tumor heterogeneities in pancreatic neuroendocrine tumors, identifying activation of cancer progression hallmarks at different stages, defining two dominant clones with metastatic potential, and developing a gene signature for predicting tumor metastatic potential validated in patient cohorts.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Add to Collection

Review Oncology

Cancer metabolism: looking forward

Inmaculada Martinez-Reyes et al.

Summary: This Perspective discusses the main themes in cancer metabolism research, focusing on the relationship between tumour initiation and progression with metabolic reprogramming, as well as the importance of tumor microenvironment and metabolic regulation.

NATURE REVIEWS CANCER (2021)

Add to Collection

Review Oncology

The metabolism of cancer cells during metastasis

Gabriele Bergers et al.

Summary: This review discusses the metabolic rewiring in cancer cells during the metastatic cascade and the distinct metabolic features of primary tumors and metastases. Metastasis is the leading cause of death in most cancer patients, and targeting metastatic seeding and colonization remains a significant challenge. Adjusting metabolism may provide therapeutic opportunities to prevent or reduce metastasis, and targeting the new metabolic traits in established metastases could lead to their eradication.

NATURE REVIEWS CANCER (2021)

Add to Collection

Editorial Material Cell Biology

The 2019 WHO classification of tumours of the digestive system

Iris D. Nagtegaal et al.

HISTOPATHOLOGY (2020)

Add to Collection

Review Oncology

New aspects of amino acid metabolism in cancer

Lisa Vettore et al.

BRITISH JOURNAL OF CANCER (2020)

Add to Collection

Review Oncology

Reprogramming of fatty acid metabolism in cancer

Nikos Koundouros et al.

BRITISH JOURNAL OF CANCER (2020)

Add to Collection

Review Endocrinology & Metabolism

Creatine metabolism: energy homeostasis, immunity and cancer biology

Lawrence Kazak et al.

NATURE REVIEWS ENDOCRINOLOGY (2020)

Add to Collection

Article Oncology

Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)

Alberto Puccini et al.

CLINICAL CANCER RESEARCH (2020)

Add to Collection

Review Cell Biology

The Complex Interplay between Antioxidants and ROS in Cancer

Isaac S. Harris et al.

TRENDS IN CELL BIOLOGY (2020)

Add to Collection

Article Oncology

Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism

Chih-Wei Chou et al.

CANCERS (2020)

Add to Collection

Article Cell Biology

Acyl-CoA-Binding Protein Drives Glioblastoma Tumorigenesis by Sustaining Fatty Acid Oxidation

Ceren Duman et al.

CELL METABOLISM (2019)

Add to Collection

Article Biochemistry & Molecular Biology

WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs

Yuxing Liao et al.

NUCLEIC ACIDS RESEARCH (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors

Paloma Cejas et al.

NATURE MEDICINE (2019)

Add to Collection

Article Oncology

A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma

Shi-Lu Chen et al.

CANCER RESEARCH (2019)

Add to Collection

Article Cell Biology

Quantitative Analysis of the Whole-Body Metabolic Fate of Branched-Chain Amino Acids

Michael D. Neinast et al.

CELL METABOLISM (2019)

Add to Collection

Review Endocrinology & Metabolism

Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms

Andrea Mafficini et al.

ENDOCRINE REVIEWS (2019)

Add to Collection

Article Oncology

Genomic profiling of NETs: a comprehensive analysis of the RADIANT trials

James Yao et al.

ENDOCRINE-RELATED CANCER (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Metabolomics of Small Intestine Neuroendocrine Tumors and Related Hepatic Metastases

Alessio Imperiale et al.

METABOLITES (2019)

Add to Collection

Article Oncology

Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy

Yihan Sun et al.

BREAST CANCER RESEARCH AND TREATMENT (2018)

Add to Collection

Article Biochemical Research Methods

Pharmacometabonomics Analysis Reveals Serum Formate and Acetate Potentially Associated with Varying Response to Gemcitabine-Carboplatin Chemotherapy in Metastatic Breast Cancer Patients

Limiao Jiang et al.

JOURNAL OF PROTEOME RESEARCH (2018)

Add to Collection

Article Cell Biology

Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

Xinxin Peng et al.

CELL REPORTS (2018)

Add to Collection

Article Pathology

A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal

Guido Rindi et al.

MODERN PATHOLOGY (2018)

Add to Collection

Article Oncology

Visceral Obesity and Metabolic Syndrome Are Associated with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors

Ana P. Santos et al.

CANCERS (2018)

Add to Collection

Article Endocrinology & Metabolism

Insights into gemcitabine resistance and the potential for therapeutic monitoring

Teklab Gebregiworgis et al.

METABOLOMICS (2018)

Add to Collection

Article Multidisciplinary Sciences

ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup

Chang S. Chan et al.

NATURE COMMUNICATIONS (2018)

Add to Collection

Article Multidisciplinary Sciences

Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas

S. R. Rosario et al.

NATURE COMMUNICATIONS (2018)

Add to Collection

Review Cell Biology

Beyond the Warburg Effect: How Do Cancer Cells Regulate One-Carbon Metabolism?

Adam Rosenzweig et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)

Add to Collection

Article Multidisciplinary Sciences

Whole-genome landscape of pancreatic neuroendocrine tumours

Aldo Scarpa et al.

NATURE (2017)

Add to Collection

Review Urology & Nephrology

Metabolic reprogramming in clear cell renal cell carcinoma

Hiromi I. Wettersten et al.

NATURE REVIEWS NEPHROLOGY (2017)

Add to Collection

Article Oncology

Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

Arvind Dasari et al.

JAMA ONCOLOGY (2017)

Add to Collection

Review Endocrinology & Metabolism

Emerging roles of lipid metabolism in cancer progression

Cyril Corbet et al.

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2017)

Add to Collection

Review Oncology

Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis

E. Leoncini et al.

ANNALS OF ONCOLOGY (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer

Weimin Wang et al.

CELL (2016)

Add to Collection

Article Oncology

Role of Increased n-acetylaspartate Levels in Cancer

Behrouz Zand et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer

Roman Camarda et al.

NATURE MEDICINE (2016)

Add to Collection

Article Multidisciplinary Sciences

Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival

Edoardo Gaude et al.

NATURE COMMUNICATIONS (2016)

Add to Collection

Article Oncology

Role of Increased n-acetylaspartate Levels in Cancer

Behrouz Zand et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)

Add to Collection

Review Cell Biology

Metabolic pathways promoting cancer cell survival and growth

Lindsey K. Boroughs et al.

NATURE CELL BIOLOGY (2015)

Add to Collection

Article Oncology

A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics

Anguraj Sadanandam et al.

CANCER DISCOVERY (2015)

Add to Collection

Article Pathology

Characterization of gene expression and activated signaling pathways in solid-pseudopapillary neoplasm of pancreas

Minhee Park et al.

MODERN PATHOLOGY (2014)

Add to Collection

Article Gastroenterology & Hepatology

Risk Factors for Pancreatic Neuroendocrine Tumors A Clinic-Based Case-Control Study

Thorvardur R. Halfdanarson et al.

PANCREAS (2014)

Add to Collection

Article Biotechnology & Applied Microbiology

Heterogeneity of tumor-induced gene expression changes in the human metabolic network

Jie Hu et al.

NATURE BIOTECHNOLOGY (2013)

Add to Collection

Article Surgery

Metabonomic profiling: A novel approach in neuroendocrine neoplasias

James M. Kinross et al.

SURGERY (2013)

Add to Collection

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

CELL (2011)

Add to Collection

Article Oncology

Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway

Edoardo Missiaglia et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Add to Collection

Article Oncology

Risk factors associated with neuroendocrine tumors: A US-based case-control study

Manal M. Hassan et al.

INTERNATIONAL JOURNAL OF CANCER (2008)

Add to Collection

Review Oncology

One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

James C. Yao et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

Add to Collection

Article Pharmacology & Pharmacy

Induction of glutathione transferase in insulin-like growth factor type I receptor-overexpressed hepatoma cells

Jeong Yong Lee et al.

MOLECULAR PHARMACOLOGY (2007)

Add to Collection

Article Multidisciplinary Sciences

Pharmaco-metabonomic phenotyping and personalized drug treatment

TA Clayton et al.

NATURE (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.